Mongolia has the world’s highest rate of liver cancer mortality; nearly eight times the global average. The prevalence of chronic viral hepatitis B, C, and D is at endemic level, and constitutes the main reason cause of Mongolia’s world-leading liver cancer mortality rate. To tackle this deadly crisis, the Onom Foundation, Patient and Civil Society Council, Mongolian Gastroenterology Association, and Mongolian Society of Hepatology launched the Hepatitis Prevention, Control, and Elimination (HPCE).
THE EASL INTERNATIONAL LIVER FOUNDATION JOINED FORCES FOR THE FIRST TIME WITH THE SAUDI ASSOCIATION FOR THE STUDY OF LIVER DISEASES AND TRANSPLANTATION SASLT
The EASL International Liver Foundation joined forces for the first time with the Saudi Association for the Study of Liver Diseases and Transplantation SASLT in a common educational initiative which took place in Jeddah, Kingdom Saudi Arabia on September 29th, 2017. The meeting produced lively interactive scientific discussions between experts from Saudi Arabia and Europe on a variety of liver diseases.
THE EASL INTERNATIONAL LIVER FOUNDATION TO HOLD ITS FIRST INTERNATIONAL CONSULTATIVE MEETING ON ELIMINATION OF VIRAL HEPATITIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN NEW ORLEANS, LA USA
The EASL International Liver Foundation to hold its first international consultative meeting on elimination of viral hepatitis in patients with chronic kidney disease in New Orleans on November 1st 2017. The meeting is the result of a strategic partnership between the Foundation and the European Renal Association
THE EASL INTERNATIONAL LIVER FOUNDATION POISED TO INITIATE A NEW COLLABORATION WITH THE EUROPEAN HAEMOPHILIA CONSORTIUM
A new collaboration between the EASL International Liver Foundation and the European Haemophilia Consortium is expected to take place over the coming months. The two organisations held a consultative meeting in Vilnius, Lithuania on Friday, October 6th, 2017.
THE THALASSEMIA INTERNATIONAL FEDERATION AND THE EASL INTERNATIONAL LIVER FOUNDATION TO HOLD FIRST CONSULTATION MEETING IN THESSALONIKI, GREECE
The Thalassemia International Federation and the EASL International Liver Foundation are set to hold the first consultative meeting in Thessaloniki, Greece on November 17th 2017 on viral hepatitis elimination.